- Science-driven: a platform to advance HIV prevention research. Responds to a growing consensus that effective prevention will require a combination of scientific approaches across the various fields.
- Collaborative: encourages cross-fertilization among research on HIV vaccines, microbicides, treatment as prevention, and other biomedical prevention approaches.
- Inclusive: scholarships for early career investigators, community advocates and journalists, and participation from resource-limited settings is a funding priority.
- Focused: on biomedical HIV prevention research findings, questions and priorities specific to each approach.
The conference will convene the world’s experts in HIV prevention and related fields to:
- Present new scientific research findings, and enhance global scientific collaborations and knowledge, in all aspects of biomedical HIV prevention research, implementation, review, education, and access.
- Refine HIV prevention research agendas to reflect identified opportunities and knowledge gaps, including those related to:
- next generation HIV vaccines and bNAbs;
- the primary and secondary use of antiretroviral drugs for prevention (TasP and PrEP), innovative uses of ART for prevention including longer-acting and multi-purpose applications, and PrEP roll-out and long-term PrEP use;
- reducing HIV stigma and expanding access to prevention, with a focus on reaching displaced and more difficult-to-reach populations;
- maximizing the impact of innovations in HIV testing;
- integrating HIV prevention agendas across disease and risk areas, co-morbidities, related fields of health including sexual and reproductive health and noncommunicable diseases, and concomitant epidemics such as that of opioid misuse;
- the responsive and effective design and implementation of HIV prevention trials.
- Advance evidence-informed and human rights-based HIV prevention approaches, tailored to reduce health disparities and meet the needs of particularly at risk and vulnerable groups including: adolescents, young adults and women in high-burden settings, displaced populations, men who have sex with men, prisoners and other incarcerated people, people who use drugs, sex workers, and transgender people.
- Share information on advances and challenges related to generating support and funding for biomedical HIV prevention.